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Translation, cross-cultural adaptation and validation of the DYMUS questionnaire for the assessment of dysphagia in
multiple sclerosis. The original English version of the DYMUS was translated using the forward-backward technique,
cross-culturally adaptated, pilot-tested in 40 patients, and then applied to 100 multiple sclerosis patients to assess
the reliability and construct validity. Construct validity was assessed by Mann–Whitney test and Spearman’s
correlation coefficient (rs). The internal consistency of the questionnaire was evaluated using Cronbach’s alpha
coefficient and inter-item correlation. DYMUS-BR internal consistency was high (Cronbach’s alpha= 0.72); Cronbach’s
alpha was 0.65 for the ‘dysphagia for solids’ subscale and 0.67 for the ‘dysphagia for liquids’ subscale and positive
inter-item correlations was found between all items, except for weight loss question. Significant association
(p<0.001) and correlation (rs = 0,357; p = 0.01) was found between DYMUS-BR and dysphagia self-assessment. The
DYMUS-BR questionnaire maintained the characteristics of that originally described, demonstrating to be a reliable,
valid, easy and consistent tool to be used by health professionals for preliminary selection of Brazilian MS patients
who need more specific instrumental analyses of swallowing.
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Oropharyngeal dysphagia in Multiple Sclerosis (MS) is a
relatively common symptom, occurring in 33 - 43% of
MS patients (Hartelius & Svensson 1994; Prosiegel et al.
2004; Terré-Bolliart et al. 2004). It can increase signifi-
cantly with disease progression; impairment in the cere-
bellar (Poorjavad et al. 2010; De Pauw et al. 2002) and
brainstem function systems (De Pauw et al. 2002; Leder
et al. 1998). The impact of dysphagia is significant, redu-
cing the quality of life and increasing risk of dehydration
and aspiration pneumonia in this population. These compli-
cations can be prevented through a rapid screening protocol
for the risk of dysphagia in these patients (Poorjavad et al.* Correspondence: regina_alvarenga@hotmail.com
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in any medium, provided the original work is p2010). In this scenario, the identification of dysphagia
symptoms in early stages of MS allows referral to more
specific investigations by specialized professional, which
includes the use of instrumental deglutition evaluations
such as the videofluoroscopy swallowing study (VFSS) and
transnasal fibreoptic endoscopic evaluation of swallowing
(FEES). Early diagnosis can also make it possible to imple-
ment preventive measures, and thus to reduce the risk of
complications such as aspiration pneumonia.
To identify the risk of dysphagia in MS, Bergamaschi et al.
(2009) developed a simple questionnaire, the DYMUS
(Questionnaire for the assessment of Dysphagia in Mul-
tiple Sclerosis) (Bergamaschi et al. 2008), validated in
2010 in a large number of patients (Bergamaschi et al.
2009). This instrument is the first questionnaire developed
specifically for patients with MS. The DYMUS question-
naire proved to be a useful and consistent instrument to
detect oropharyngeal dysphagia and its main features in
MS. It can also be used to identify individuals in need ofOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Socio-demographic and clinical characteristics of





Age (years), N (%)
< 50 anos 71 (71,0)
50 anos ou mais 29 (29,0)
MSa subtype, N (%)
Relapsing remitting 66 (66,0)
Primary progressive 18 (18,0)




























a MS multiple sclerosis.
b EDSS expanded disability status scale.
c FS functional system.
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programs for prevention of aspiration. It also showed a
very good correlation with swallowing problems and
Expanded Disability Status Scales (EDSS) scores. Fur-
thermore, it was associated with a very good internal
consistency for both “dysphagia for solid” and “dysphagia
for liquid” subscales (Bergamaschi et al. 2008, 2009).
The purpose of this study was to translate, cross-
culturally adapt and validate to Portuguese the DYMUS
questionnaire for the assessment of dysphagia in Mul-
tiple Sclerosis.
Results
In total, 100 patients were included into the validation
study. Sixty-nine percent of the patients was female. The
mean age of the patients was 42.5 years, with a range
between 13 and 69 years. The majority of patients (66.0%)
had a relapsing-remitting form of MS. The median dis-
ease duration of the participants was 8 years (range: 0–
40 years), and their median EDSS score was 3 (range:
0–9). At the time of the interview 15 patients (15.0%)
claimed to have swallowing problems (Table 1).
Table 2 shows the percentages of positive responses to
the DYMUS single questions. The mean DYMUS score
was 1.58 (SD 1.95, range 0–8). The difficulty swallowing
solid food (question # 1) and food sticking (question # 4)
items showed the lowest frequency of positive responses
(≤10%). According to DYMUS-BR, 58,0% of the patients
were classified as having dysphagia, 31,0% had dysphagia
for liquid food (positive scores on questions 2, 6 or 9) and
53.0% dysphagia for solid food (positive scores on ques-
tions 1, 3, 4, 5, 7, 8 or 10); 26.0% had dysphagia for
solids and liquids simultaneously. For the 85 patients
who reported no difficulty in swallowing by the initial
question, 43 (50.6%) had positive responses to the DYMUS
questionnaire and 11 of these (12.9%) were classified as
having alarming dysphagia. The DYMUS questionnaire
detected 3.5 times more dysphagia (53.0% versus 15.0%)
than patients’ self-assessment. Regarding the severity of
dysphagia, 36.0% of patients were classified as mild dys-
phagia and 22.0% as alarming dysphagia, while most
cases of mild dysphagia (33/36 = 91.7%) had not responded
to the initial question “Do you have difficulty swallowing?”.
Almost half of alarming cases (10/22 = 45.5%) answered
no to that same question. The Cronbach’s alpha value of
the DYMUS-BR was estimated to be 0.72, representing
a high internal consistency, demonstrating consistency of
the questionnaire items after translation to the Portuguese
language. Cronbach’s alpha coefficients of the 2 subscales
dysphagia for solids and liquid were also calculated: The
Cronbach’s alpha of the 7-item dysphagia for solids ques-
tionnaire was 0.65 while that of the 3-item dysphagia for
liquids questionnaire was 0.67. By analyzing the matrix of
inter-item correlations (Table 3), a positive correlationbetween all items, except question 10 (“weight loss” item),
was found. Question 10 had also the lowest correl-
ation coefficient. For the remaining questions (1 a 9)
the inter-item correlation coefficients between scores
ranged from 0.044 (between “food sticking” and “cough or
choking sensation” questions) to 0. 595 (between “difficulty
Table 2 Percentages of positive responses to the DYMUS-BR single questions
DYMUS-BR questions N (%)
1. Do you have difficulty swallowing solid food (such as meat, bread and the kike)? 10 (10,0)
2. Do you have difficulty swallowing liquids (such as water, milk and the like)? 17 (17,0)
3. Do you have globus sensation (the feeling of a lump) in your throat when swallowing? 17 (17,0)
4. Does food stick in your throat? 7 (7,0)
5. Do you cough or have a choking sensation after ingesting solid food? 15 (15,0)
6. Do you cough or have a choking sensation after ingesting liquids? 22 (22,0)
7. Do you need to swallow several times before solid foods “goes down” completely? 14 (14,0)
8. Do you need to cut food into small pieces be able to swallow it? 24 (24,0)
9. Do you need to take many sips in order to drink? 14 (14,0)
10. Have you lost weight? 18 (18,0)
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questions).
Construct validity was assessed by using a single-item
assessment of perceived dysphagia. Individuals who reported
dysphagia in the initial query “Do you have difficulty
swallowing?” obtained a significantly higher DYMUS-BR
score (median 5, range 1 – 8) compared with those not
perceiving dysphagia (median 1, range 1–6), supporting
the ability of the questionnaire to discriminate between
individuals with and without dysphagia (p<0.001). In
addition, Spearman’s correlation coefficients were posi-
tive (rs = 0,357) and show that there was a significant
correlation between the both measures (P value= 0.01),
suggesting that the two scales were virtually inter-
changeable in assessing dysphagia.
Discussion
Until the year 2008, it had not been described in the
scientific literature any assessment tool to access the
risk of dysphagia specifically in MS patients. Bergamashi
and his coworkers (Bergamaschi et al. 2008, 2009) devel-
oped and validated in a large population (1,734 patients)
the DYMUS questionnaire, the subject of this study.
The translation, cross cultural adaptation and validation
of questionnaires must be carefully performed. Beaton et al.Table 3 Reliability analysis based on the DYMUS_BR inter-item
Question 1 Question 2 Question 3 Question 4 Questio
Question 1 1,000
Question 2 ,204 1,000
Question 3 ,293 ,150 1,000
Question 4 ,300 ,189 ,189 1,000
Question 5 ,420 ,332 ,257 ,434 1
Question 6 ,306 ,595 ,145 ,044
Question 7 ,442 ,124 ,124 ,228
Question 8 ,281 ,369 ,182 ,213
Question 9 ,250 ,354 ,124 ,115
Question 10 ,017 -,004 ,134 -,027
* In bold, negative correlations.(1976) emphasized that a poor translation process can
result in a non-equivalent to the original instrument.
The lack of equivalence can limit the comparison of re-
sults obtained in populations separated by their own
languages and cultures. In this study, the careful execu-
tion of each of these steps aimed the maintenance of
the unique properties of the questionnaire, which was
reinforced by conducting a pilot study with 40 MS pa-
tients and the participation of the experts committee,
ensuring content and comprehensibility validity (or face
validity) of the Brazilian version of the questionnaire.
In the validation set, more than half (50.6%) of the
85 patients who reported no difficulty in swallowing in
the initial question had positive responses to the DYMUS
questionnaire and 12.9% of these were classified as having
alarming symptoms of dysphagia, pointing to a significant
percentage of silent cases, who were identified only by
DYMUS. Although we have no knowledge of another
published study using the DYMUS questionnaire by way
of discussion, we cite the study of Terré-Bolliart et al.
(2004) in which, correlating the clinical and VFSS
evaluations, found differences in the results obtained
by these different forms to assessment of dysphagia,
emphasizing the importance of the association of clinical
and instrumental methods to evaluate the swallowingcorrelation




,420 ,323 ,313 1,000
,153 ,273 ,336 ,246 1,000
,095 ,003 ,036 -,020 ,036 1,000
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studied patients with MS through VFSS, and found
swallowing disorders in 75% of patients without clinical
signs and symptoms of dysphagia, demonstrating that
even patients without symptoms or complaints of dyspha-
gia may have impairments in swallowing. Leder et al.
(1998) detected silent aspiration in half of the patients
with different neurological degenerative disorders, in-
cluding multiple sclerosis. These results point to the
importance of early identification of MS patients with
risk of dysphagia, especially those without clinically
evident symptoms of swallowing disorders.
By applying DYMUS-BR, 58% of patients were classi-
fied as having some type of swallowing disorder. In the
original study developed by Bergamaschi et al. (2008),
the prevalence of dysphagia measured by DYMUS was
35%. On the other hand, in the DYMUS validation process
(Bergamaschi et al. 2009), 31% of patients had at least one
abnormal response on the questionnaire. Using other
methods to determine the prevalence of dysphagia in
MS patients, Poorjavad et al. (2010) found that 31.7% of
the 101 analyzed patients had dysphagia.
The higher values obtained in our study may be attrib-
uted to the absence of obvious clinical signs and symp-
toms of swallowing disorders.
The final version of the DYMUS-BR questionnaire, whose
internal consistency was classified as high (Cronbach’s alpha
coefficient 0.730), can be considered as reliable, due to the
degree of homogeneity of items. The subscales dysphagia
for liquids (Cronbach’s alpha coefficient = 0.673) and dys-
phagia for solids (Cronbach’s alpha coefficient = 0.670)
showed satisfactory internal consistencies. In the original
validation of the DYMUS, Bergamaschi et al. obtained, the
following coefficients: 0.914 (10-item DYMUS question-
naire), 0.885 (dysphagia for solids) and 0.864 (dysphagia
for liquids) (Bergamaschi et al. 2009).
In the original version of the DYMUS questionnaire,
the question 10 (do you have weight loss?) Was less cor-
related to other questions, getting still the second lowest
frequency of positive responses (8.3%), but even so it has
been kept in the questionnaire.in our study, question 10
was also the only one which was not a positive correlation
and low correlation coefficient. this can be explained by
the fact that in our study, the mean disease duration of
MS patients was 8 years old, with a median EDSS of 3,
which shows no or mild degree of disability. The associ-
ation between weight loss and dysphagia is found in the
evolutionary course of neurological disorders, being found
more often in advanced stages of the disease, where there
is greater functional dependency and difficulty swallowing,
which may explain the lower scores on question 10.
To our knowledge, there is only one validation study
of the DYMUS questionnaire (Bergamaschi et al. 2009).
Because of this, by way of comparison, the resultsobtained were analyzed in the light of other validation
studies for the diagnosis of dysphagia. For the construct
validity, Dwivedi et al. (2010) have analyzed a cohort of
31 head and neck cancer patients using the correlation
coefficient and Mann–Whitney U-test in the validation
process of the Sydney Swallow Questionnaire. Both were
statistically significant (P <0.01), as in the present study.
In the validation process of the Mayo Dysphagia Ques-
tionnaire, Grudell et al. (2007) found excellent Spearman
rank correlation coefficients values (range of 0.87-0.98).
In another study, Chen et al. (2001) developed and vali-
dated a dysphagia-specific quality-of-life questionnaire
for head and neck cancer patients with Spearman rank
correlation coefficients between 0.21 and 0.52. In the
current study the coefficient was 0.357, indicating sig-
nificant positive correlations (P value = 0.01).
The main limitation of our study was that DYMUS is
a screening test and like other screening procedures was
designed to identify high-risk patients with a specific
problem and has been designed to detect signs of dys-
phagia and its main characteristics in MS patients. Fu-
ture studies should be focused to analyze correlations
between the DYMUS-BR scores and instrumental tools
for evaluations of dysphagia such as Videofluoroscopy
or FEES. Studies with larger populations are also needed
in order to better analyze the types and characteristics
of oropharyngeal dysphagia in Brazilian patients with
Multiple Sclerosis.
Conclusion
In conclusion, the Brazilian version of the DYMUS ques-
tionnaire kept the features originally described, demon-
strating to be a reliable, valid, consistent and easy tool to
detect the risk of dysphagia in MS patients, that can also
be used by healthcare professionals to pre-select patients
who could be submitted for more specific instrumental




A sample of MS patients based on the McDonald criteria
(McDonalds et al. 2001) in the clinical types Relapsing-
Remitting (RRMS), Primary Progressive (PPMS) and
Secondary Progressive (SPMS), who were visited at the
Multiple Sclerosis outpatient Clinic of Hospital of Lagoa,
Rio de Janeiro, Brazil, were recruited to this study between
August 2009 and June 2010.
Patients with other idiopathic demyelinating diseases;
patients with no confirmed MS diagnosis; patients in an
acute relapse; and patients incapable of verbal commu-
nication were excluded from this study. The authors of
the original version of the DYMUS questionnaire autho-
rized the translation and cross-cultural adaptation to
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Ethics and Research Committee of Federal University of
the State of Rio de Janeiro –UNIRIO (no 0036.000-09) and
all patients signed the informed consent form.
Instrument
The DYMUS is a self-reported questionnaire composed
by 10 questions that evaluate two dimensions: dysphagia
for solids (positive scores in questions 1, 3, 4, 5, 7, 8 or 10)
and dysphagia for liquids (positive scores in questions 2, 6
or 9). All the answers are dichotomous, coded as 1 or 0,
depending on the presence or the absence of the event.
The total score is achieved by the sum of the two dimen-
sions, ranging from 0 to 10 points. Dysphagia is identified
by at least one abnormal response and is considered
alarming when the score is equal to or higher than three
(Bergamaschi et al. 2008, 2009).
At the time of the examination all the patients were
asked whether they had swallowing problems and after
that, irrespective of their response, the DYMUS question-
naire was administered by a trained speech pathologist.
The Expanded Disability Status Scale (FS/EDSS) (Kurtzke
1983) was used as a standardized neurological examination.
The EDSS assesses neurological impairment and disability
and was performed by a trained doctor. EDSS score varies
between 0 and 10, a high score indicates a more severe
disability (Sonder et al. 2012; Kurtzke 1983).
Translation, back-translation and cross-cultural adaptation
of questionnaire
The translation, including forward and backward trans-
lations, and the cross-cultural adaptation of the DYMUS
questionnaire were carried out according to international
standards. The criteria proposed by Guillemin et al. (1993)
and Beaton et al. (1976) we used, fulfilling the 5 steps for
translation and cultural adaptation. The original version of
the DYMUS questionnaire was translated to Portuguese
by two Brazilian translators who were fluent in English,
one being a health professional (speech and language
therapist) and the other with no technical/scientific know-
ledge of the topic under study. The two translations were
compared by the researcher in charge and the required
adjustments were subsequently made with the consent
of both translators resulting into a single version of the
translation. This version was back translated into English
by two bilingual translators, whose mother tongue is
English, who had no access to the original English ver-
sion of the questionnaire, thus preserving its ambiguity.
The backward translation was compared and considered
equivalent to the original version.
In the second phase of the study, comprehensibility
and content validity of the questionnaire were tested using
cognitive interviews with 40 MS patients (pilot study). In
order to improve the intelligibility of the instrumentswhen necessary and optimize the face and content validity
for the main study, each patient was asked to explain what
had understood about each question.
A committee composed by four health professionals
with experience in neurology and dysphagia (one speech
therapist, two neurologists and one physical education),
bilingual, revised the produced versions in light of the
difficulties presented by patients, making the semantic
and idiomatic modifications as necessary. Questions 1, 2,
5, 8 and 10 were comprised of 100% of patients. Based
on the information obtained, adjustments had to be made
to questions 3, 4, 6, 7 and 9, besides substituting the words
“deglute and deglutition” for “swallow”, given that those
words were not understood by the patients. Furthermore,
one patient had difficulty understanding the question 3
(2.5%), two (5.0%) in question 4 and 6, three (7.5%) on
question 9 and 11 in question 7 (27.5%).
The definitive Brazilian version, named DYMUS-BR,
was produced after the face and content validity results
in the pilot study had been approved by this committee.
The final version of the questionnaire was maintained with
10 questions, similar to the original version (Additional
file 1).
Reliability and construct validity
To evaluate the reliability of the DYMUS-BR questionnaire
we computed Cronbach alpha (Cronbach 1951), which is a
reliability coefficient based on internal consistency. The
internal consistency was estimated by Cronbach’s alpha
coefficient for dysphagia as a whole and for dysphagia
for solid and liquid. The Cronbach’s alpha coefficient
was analyzed according to the Instrument Review Criteria
(SAC): between 0 to 0.6 unsatisfactory reliability, between
0.6 to 0.7 satisfactory reliability, and between 0.7 to 1.0
high reliability (Scientific Advisory Committee of the
Medical Outcomes Trust – SAC Instrument Review Cri-
teria 1995). A questionnaire can be considered reliable if
obtains values between 0.65 and 1 (Scientific Advisory
Committee of the Medical Outcomes Trust – SAC In-
strument Review Criteria 1995). In order to evaluate item
homogeneity we computed the inter-item correlation
matrix. Construct validity was evaluated by testing the
operationalization of the measure dysphagia of the ques-
tionnaire against the patients’ self-assessment of dyspha-
gia, used as a proxy, measured by the response to the
initial question “Do you have difficulty swallowing?”. To
achieve this, a cross-sectional study was performed. As
recommended by (Dawson & Trapp 2004) the minimum
number of patients to be tested should correspond to 10
patients for each item of the questionnaire to be validated.
As DYMUS questionnaire has ten items, the inclusion of
100 patients was sufficient. Mann–Whitney U test was
used to determine if differences existed and Spearman’s
rank correlation coefficient (rs) was used to assess the
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patient’s self-assessment.
Data analysis
The descriptive analysis was conducted for characterization
of the socio-demographic and clinical data of the patients.
Categorical variables were shown as percentages. Continu-
ous variables were shown as average or mean along with
the respective standard deviation or percentile. The answers
to the DYMUS-BR questionnaire were grouped into: with-
out dysphagia (zero score) and dysphagia (1 or more abnor-
mal response). Patients with dysphagia were classified as:
dysphagia for solids (positive scores on questions 1, 3, 4, 5,
7, 8 or 10) or: dysphagia for liquids (positive scores on
questions 2, 6 or 9). Moreover, dysphagia was classified as
mild (1 or 2 abnormal responses) or alarming (3 or more
abnormal responses) (Bergamaschi et al. 2008, 2009).
Cronbach’s alpha coefficient, inter-item correlation matrix,
Mann–Whitney U test and Spearman’s rank correlation
coefficient were used. A significance level of 0.05 was set.
Data analyses were performed using Statistical Package
for Social Sciences (SPSS), version 14.0, 2006 for win-
dows software.
Additional file
Additional file 1: The English original version of the DYMUS
questionnaire and the Brazilian final version of the DYMUS-BR
questionnaire.
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